FDA Embraces AI To Accelerate Drug Review Process

forbes.com/sites/torconstantino/2025/05/22/fda-embraces-ai-to-accelerate-drug-review-process

In a landmark for U.S. public health digital transformation, the FDA said it will deploy generative AI enterprise-wide by the end of June 2025.

This story appeared on forbes.com, 2025-05-22 12:00:00.
The Entire Business World on a Single Page. Free to Use →